Company Filing History:
Years Active: 1995
Title: Barbara Alving: A Pioneer in Hematology Innovations
Introduction
Barbara Alving, based in Bethesda, MD, is a distinguished inventor renowned for her significant contributions to the field of hematology. With a total of two patents to her name, she has developed innovative methodologies that enhance the understanding and treatment of thrombotic conditions. Alving's work reflects her commitment to improving clinical practices and patient outcomes.
Latest Patents
Barbara Alving's recent patents showcase her expertise and ingenuity. The first, titled "Test for Quantitative Thrombin Time," offers a quantitative method for determining plasma levels of thrombin-specific inhibitors. This method utilizes plasma dilutions and excess fibrinogen to provide more reliable results than standard coagulation tests, making it suitable for routine performance in clinical hematology laboratories.
Her second patent, "Method of Lysing Thrombi," focuses on prevention and treatment strategies for thrombi. By using plasminogen activators, such as t-PA, urokinases, and streptokinases, in conjunction with intermittent ultrasound, Alving’s invention enhances the efficacy of thrombus treatment. This method employs a liquid-containing interface to optimize ultrasound application, further refining therapeutic approaches in treating thrombotic disorders.
Career Highlights
Barbara Alving is affiliated with the U.S. Government, specifically represented by the Secretary of the Army. Her role within this esteemed institution exemplifies her dedication to advancing medical science, particularly in hematology. Throughout her career, Alving has made strides in translating research into practical applications that benefit both clinicians and patients.
Collaborations
Barbara Alving has worked alongside esteemed colleagues, including Carl G. Lauer and Thomas J. Reid, III. Their collaborative efforts reflect a shared commitment to innovation in the medical field, fostering a dynamic environment where groundbreaking ideas can flourish.
Conclusion
Barbara Alving is a trailblazer in hematology, with her inventions contributing to vital advancements in thrombus treatment and diagnosis. Her dedication to innovation and her impactful patents underline her invaluable role in the medical community. Through her continued work and collaboration with colleagues, Alving is paving the way for future innovations in the field.